The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Female Fertility And Pregnancy Rapid Test Market Expected To Scale Between 2026 And 2030?
The female fertility and pregnancy rapid test market has experienced considerable growth in recent years. It is anticipated to expand from $1.48 billion in 2025 to $1.58 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. The historical drivers for this growth include an elevated awareness of female reproductive health, the increased adoption of ovulation predictor kits, wider retail availability of rapid tests, the expansion of hospital-based diagnostic testing facilities, and a rising incidence of infertility diagnoses.
The female fertility and pregnancy rapid test market size is anticipated to expand significantly in the coming years, projected to reach $2.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth over the forecast period stems from factors like a rising demand for early pregnancy detection, the increasing adoption of digital health monitoring solutions, a heightened focus on personalized fertility management, the broadening scope of telehealth-supported diagnostics, and deeper penetration of e-commerce in healthcare products. Concurrently, major trends for this period encompass a greater embrace of at-home rapid testing kits, an increasing desire for digital and app-connected test devices, the growing use of combined fertility and pregnancy tests, the expansion of online distribution channels, and an intensified focus on user-friendly and accurate test designs.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp
Which Primary Drivers Are Impacting The Female Fertility And Pregnancy Rapid Test Market Growth?
The rising prevalence of gynecological conditions is anticipated to propel the expansion of the female fertility and pregnancy rapid test market moving forward. Gynecological problems are medical ailments affecting female reproductive organs, specifically the breasts and abdominal and pelvic structures such as the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. A rapid female fertility and pregnancy test assists in managing gynecological disorders by enabling early detection of hormonal imbalances or pregnancy-related issues, thereby supporting timely diagnosis and effective management of reproductive health conditions. For instance, in May 2025, a report from the National Library of Medicine, a US-based government organization, indicated that approximately 61.2% of women experienced at least one gynecological morbidity, with dysmenorrhea being the most common (61.3%), followed by irregular menses (36.1%) and infertility (36.1%). Therefore, the increasing incidence of gynecological disorders is driving the growth of the female fertility and pregnancy rapid test market.
What Are The Different Segment Types In The Female Fertility And Pregnancy Rapid Test Market Segment Breakdown?
The female fertility and pregnancy rapid test market covered in this report is segmented –
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2) By Device Type: Digital Devices, Line-indicator Devices
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel
Subsegments:
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests
Which Trends Are Shaping Growth In The Female Fertility And Pregnancy Rapid Test Market?
Leading companies in the female fertility and pregnancy rapid test market are prioritizing the creation of innovative solutions, such as at-home saliva-based pregnancy tests, to address the increasing demand for non-invasive options. A saliva-based pregnancy test operates as a lateral-flow, point-of-care assay designed to detect pregnancy biomarkers in oral fluid, rather than urine. For example, in May 2024, Abingdon Health plc, a UK-based lateral flow CDMO, unveiled the world’s first Boots-branded saliva pregnancy self-test (available both in Boots stores and online), thereby integrating this saliva-based technology into mainstream retail. This product features a saliva collection interface and a proprietary lateral-flow immunoassay, developed in conjunction with Salignostics and Crest Medical, specifically engineered to identify and indicate the presence of the pregnancy biomarker in oral fluid; it functions as a rapid, single-use self-test that provides results within minutes and is packaged for over-the-counter purchase. It distinctly removes urine collection from the testing procedure, thereby improving comfort and hygiene, and facilitates consumer adoption through a familiar “stick/cassette” format. Its primary intent is for routine home screening and early confirmation of pregnancy, benefiting from Boots’ significant retail reach and consumer trust.
Who Are The Well-Known Companies In The Female Fertility And Pregnancy Rapid Test Market?
Major companies operating in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.
Get The Full Female Fertility And Pregnancy Rapid Test Market Report:
Where Is The Female Fertility And Pregnancy Rapid Test Market Primarily Concentrated By Region?
North America was the largest region in the female fertility and pregnancy rapid test market in 2025. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Female Fertility And Pregnancy Rapid Test Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=8966&type=smp
Browse Through More Reports Similar to the Global Female Fertility And Pregnancy Rapid Test Market 2026, By The Business Research Company
Fertility Treatments Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Fertility Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
Male Fertility Market Report 2026
https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model